Janssen Pharmaceuticals
Search results
Explore Janssen’s innovative medical research & pharmaceutical product development practices to see how Janssen is creating a future where disease is a thing of the past.
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen .
Oct 16, 2023 · In total, 19 studies (17 company-sponsored abstracts and two investigator-initiated studies), including seven late-breaking abstracts, will feature new data and updates in lung cancer, bladder cancer, and prostate cancer, highlighting Janssen’s pioneering efforts to transform the treatment of solid tumors.
The Janssen Pharmaceutical Companies of Johnson & Johnson | 1,024,765 followers on LinkedIn. At Janssen, we never stop working toward a future where disease is a thing of the past.
Nov 30, 2021 · “Ibrutinib was the first approved Bruton’s tyrosine kinase inhibitor and over the past seven years has become a key treatment for CLL and some other B-cell malignancies, treating more than 250,000 patients globally,” said Dr. Edmond Chan, EMEA Therapeutic Area Lead Haematology, Janssen-Cilag Ltd.
Apr 22, 2024 · BEERSE, BELGIUM (April 22, 2024) – Janssen-Cilag International NV, a Johnson & Johnson company, announced today that the European Commission (EC) has approved a Type II variation for CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel).
Jun 12, 2024 · At Janssen, we believe transparency of clinical trial data advances science and medicine, and is in the best interest of the patients who use our pharmaceutical products and providers who prescribe them.
- www.who.int
- › Newsroom
- › Feature stories
- › Detail
The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim recommendations for the use of the Janssen Ad26.COV2.S COVID-19 vaccine against COVID-19. Here is what you need to know.
Janssen ist eines der weltweit führenden forschenden Pharmaunternehmen. Als Teil des globalen Gesundheitsunternehmens Johnson & Johnson arbeiten wir daran, Krankheiten zu heilen, Schmerzen zu lindern und Leben zu verlängern.
Cilag AG is part of Janssen, the pharmaceuticals division of Johnson & Johnson*, and produces pharmaceutical and medical products and active ingredients. The company is a strategic market launch and manufacturing location for some of Johnson & Johnson’s most important pharmaceutical products.
